BioPharma Clinical Trials
Avance Clinical Briefs 45 Korean Biotechs on Global Drug Development
Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy...
October 23, 2023 | News
Regeneron and Sanofi Share Latest on Dupixent® sBLA for Chronic Urticaria
CSU is an inflammatory skin condition, which causes sudden and debilitating hives and swelling on the skin. The CRL states that additional efficacy data ar...
October 23, 2023 | News
Aculys Pharma's Positive Phase 3 Update on Diazepam Nasal Spray for Epileptic Seizures in Japan
These results are from Japan's first domestic Phase 3 clinical trial of an intranasally administered antiepileptic drug for Japanese patients a...
October 19, 2023 | News
Bio4t2 Trials CAR-T for Solid Tumors Without Lymphodepletion
The PrismCore platform generates CAR-T that recognizes overexpressed self-antigens on solid tumors. Bio-Engine adapts the CAR-T to transiently recogni...
October 18, 2023 | News
CANbridge Reaches Full Enrollment in Phase 2 Trial for Gaucher Disease in China
Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...
October 17, 2023 | News
TaiMed Reports Major Advances in Clinical Trials for New HIV Treatment in Taiwan
TaiMed Biologics, an innovation-driven biotech company dedicated to serving unmet healthcare needs, has announced favorable results and the successful comp...
October 17, 2023 | News
Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment
The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...
October 16, 2023 | News
HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192
HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...
October 13, 2023 | News
Suvoda Enhances IRT for Precise Clinical Trial Drug Supply
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system...
October 12, 2023 | News
CanariaBio and Hikma Sign Oregovomab Distribution and License Deal for MENA Region
"We are thrilled to partner with Hikma, a company with a strong presence in the MENA region and a proven track record of successful collaborations," said&n...
October 11, 2023 | News
CANbridge's CAN108 (LIVMARLI®) Receives Approval in Taiwan for ALGS-Related Pruritus
CANbridge Pharmaceuticals Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development ...
October 09, 2023 | News
Innovent Initiates Phase 3 Study of Efdamrofusp Alfa for Age-related Macular Degeneration
nnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...
October 09, 2023 | News
Veramed expands its global footprint by acquiring Clinical Trial Data Services (CTDS)
Specialist Biometrics CRO, Veramed, announced the acquisition of Boston-based data management, biostatistics and medical writing company, CTDS. The d...
October 06, 2023 | News
Emmes acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical inn...
October 06, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
